Bristol-Myers Squibb buy klostergang
Start price
08.09.17
/
50%
€56.59
Target price
08.03.18
€67.65
Performance (%)
6.63%
End price
08.03.18
€59.63
Summary
This prediction ended on 08.03.18 with a price of €59.63. The BUY prediction by klostergang finished with a performance of 6.63%. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bristol-Myers Squibb | 7.301% | 7.301% | -27.660% | -28.096% |
iShares Core DAX® | 0.039% | 0.567% | 12.281% | 14.748% |
iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% | 36.769% |
iShares Nikkei 225® | -2.389% | -1.434% | 8.335% | 5.073% |
iShares S&P 500 | -2.115% | -2.351% | 22.061% | 37.971% |
Comments by klostergang for this prediction
In the thread Bristol-Myers Squibb diskutieren
klostergang stimmt der Buy-Einschätzung von Joe130978 zu
klostergang stimmt am 08.09.2017 der Buy-Einschätzung von Joe130978 mit dem Kursziel 75$ zu.
Überschrift: Bristol-Myers Squipp = Bad news kaufen!!
https://seekingalpha.com/news/3294374-bristol-myers-opdivo-outperforms-docetaxel-treatment-resistant-lung-cancer-patients-late
(Laufzeit überschritten)
Stopped prediction by klostergang for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.38
04.01.19
04.01.19
€81.18
04.11.21
04.11.21
33.28%
17.06.21
17.06.21
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€64.20
15.03.15
15.03.15
€68.00
15.09.15
15.09.15
-17.70%
15.09.15
15.09.15